Cigna Group Form 4 insider transactions

Director Eric Wiseman reports acquiring 638 shares of Cigna Group common stock on April 23, 2025.

Director George Kurian reported acquiring 638 shares of Cigna Group common stock on April 23, 2025.

Director Kimberly A. Ross reports a transaction involving Cigna Group common stock on April 23, 2025.

Director Philip Ozuah reported the acquisition and disposal of Cigna Group common stock on April 23, 2025, according to a Form 4 filing with the SEC.

Director Mark B. McClellan reports the acquisition of 638 shares of Cigna Group common stock on April 23, 2025.

Director Kathleen M Mazzarella reports the acquisition of 638 shares of Cigna Group common stock on April 23, 2025.

Director Neesha Hathi reports acquiring 638 shares of Cigna Group common stock on April 23, 2025.

Director Elder Granger acquired 638 shares of Cigna Group common stock on April 23, 2025.

Director Eric J Foss reports acquiring 638 shares of Cigna Group common stock on April 23, 2025.

Director Elder Granger exercised stock options and sold shares of Cigna Group common stock under a pre-arranged Rule 10b5-1 trading plan.

Noelle K. Eder, EVP and Global Chief Information Officer of Cigna Group, reports a sale of common stock and acquisition through the company's 401(k) plan.

Jamie G. Kates, Chief Accounting Officer of Cigna Group, reports acquisition and disposal of company stock and stock options on February 28, 2025.

EVP & Chief Health Officer David J. Brailer reports acquisition and disposal of Cigna Group stock and stock options on February 28, 2025.

Eric Palmer, EVP at Cigna Group, reports acquisition and disposal of common stock, along with a new employee stock option grant, in a recent SEC filing.

Noelle K. Eder, EVP and Global Chief Information Officer of Cigna Group, reports acquisition and disposal of company stock related to performance shares, restricted shares, and tax obligations.

Brian Evanko, a Cigna Group executive, reports the acquisition and disposal of company stock, including shares from performance awards, restricted shares, and tax withholdings, as well as ongoing 401(k) participation.

Director George Kurian reported the acquisition of phantom stock units related to deferred compensation from Cigna.

Cigna Group's CEO, David Cordani, reports acquisition and disposal of company stock, including shares received from performance awards and transactions under a 10b5-1 trading plan.

Nicole S. Jones, EVP, Chief Administrative Officer and General Counsel of Cigna Group, reports multiple transactions involving Cigna common stock, including acquisitions, disposals, and shares held in a 401(k) plan.

Cigna director Eric C. Wiseman acquired 135.4352 phantom stock units through a deferred compensation plan, increasing his total holdings to 8,235.5682 units.

Director George Kurian acquired 88.8099 phantom stock units of Cigna through a deferred compensation plan, equivalent to common stock shares.

Executive Vice President of Cigna, Eric P. Palmer, reports the acquisition of 50 shares of common stock and indirect holdings through 401(k) plans and a trust.

Director Eric C. Wiseman reports acquisition of phantom stock units in Cigna Group through a deferred compensation plan.

Director George Kurian reports acquiring phantom stock units in Cigna Group through a deferred compensation plan.

EVP & Chief Health Officer of Cigna Group, David J. Brailer, reports disposition of shares to cover tax obligations.

Director William J DeLaney III exercised stock options and sold Cigna Group shares on August 19, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Nicole Jones, a Cigna Group executive, reported exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.

Michael W. Triplett, a Special Advisor at Cigna Group, reported the exercise of stock options and the sale of common stock under a pre-arranged trading plan.

Brian C. Evanko, EVP, Chief Financial Officer and President & CEO, Cigna Healthcare, exercised stock options and sold shares of Cigna Group (CI) common stock on June 24 and 25, 2024, under a pre-arranged 10b5-1 trading plan.

Director Elder Granger exercised stock options and sold shares of Cigna Group (CI) common stock on June 17, 2024, under a pre-arranged 10b5-1 trading plan.